Abbott Laboratories
XBER:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
C
|
Cashbuild Ltd
JSE:CSB
|
ZA |
|
Delta Lithium Ltd
ASX:DLI
|
AU |
|
A
|
Avila Energy Corp
CNSX:VIK
|
CA |
|
N
|
Netel Holding AB (publ)
STO:NETEL
|
SE |
|
S
|
SonHa International Corp
VN:SHI
|
VN |
|
C
|
CK Asset Holdings Ltd
SWB:1CK
|
HK |
|
China United Insurance Service Inc
OTC:CUII
|
TW |
|
A
|
Action Electronics Co Ltd
TWSE:3024
|
TW |
|
K
|
Kindly MD Inc
NASDAQ:KDLY
|
US |
|
J
|
Japan Eyewear Holdings Co Ltd
TSE:5889
|
JP |
|
V
|
Vodafone Idea Ltd
NSE:IDEA
|
IN |
|
Berkah Prima Perkasa Tbk PT
IDX:BLUE
|
ID |
|
Platinex Inc
OTC:PANXF
|
CA |
|
HIRE Technologies Inc
XTSX:HIRE
|
CA |
|
Dateline Resources Ltd
ASX:DTR
|
AU |
|
Growthpoint Properties Australia Ltd
OTC:GRWPF
|
AU |
|
S
|
Symphony Communication PCL
SET:SYMC
|
TH |
Wall Street
Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABL
is 139.06 EUR
with a low forecast of 117.4 EUR and a high forecast of 170.66 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABL's stock price target?
Price Target
139.06
EUR
According to Wall Street analysts, the average 1-year price target for
ABL
is 139.06 EUR
with a low forecast of 117.4 EUR and a high forecast of 170.66 EUR.
What is Abbott Laboratories's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's revenue is
5%.
The projected
CAGR
for the next 3 years is
8%.
What is Abbott Laboratories's Operating Income forecast?
Projected CAGR
18%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's operating income is
13%.
The projected
CAGR
for the next 3 years is
18%.
What is Abbott Laboratories's Net Income forecast?
Projected CAGR
23%
For the last 14 years the
compound annual growth rate for
Abbott Laboratories's net income is
2%.
The projected
CAGR
for the next 3 years is
23%.
